<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment of <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> in low-income countries (LIC) is difficult </plain></SENT>
<SENT sid="1" pm="."><plain>This report summarizes treatment of <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> by pediatric hematologists from 15 LIC who participate in the Monza International School of Pediatric Hematology/<z:hpo ids='HP_0002664'>Oncology</z:hpo> (MISPHO) </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with severe <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> were treated with low dose <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi>, which safely reduced vaso-occlusive crises </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> fared poorly due to lack of availability and high cost of anti-thymocyte globulin and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and lack of access to stem cell transplantation </plain></SENT>
<SENT sid="4" pm="."><plain>Appropriate therapy was most likely to occur in MISPHO centers with an active twinning program with a center in a high-income country </plain></SENT>
</text></document>